Verastem, Inc. (VSTM)
6.15
+0.34
(+5.85%)
USD |
NASDAQ |
Mar 05, 16:00
6.10
-0.05
(-0.81%)
After-Hours: 20:00
Verastem Cash from Investing (Quarterly) : -1.345M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| ADMA Biologics, Inc. | -0.276M |
| Zevra Therapeutics, Inc. | -4.576M |
| Immuneering Corp. | -0.0073M |
| Tango Therapeutics, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.95M |
| Cash from Financing (Quarterly) | 98.58M |
| Free Cash Flow | -147.13M |
| Free Cash Flow Per Share (Quarterly) | -0.3753 |
| Free Cash Flow to Equity (Quarterly) | -28.99M |
| Free Cash Flow to Firm (Quarterly) | -30.88M |
| Free Cash Flow Yield | -33.61% |